What the treatment can and cannot address
Diabetic retinopathy affects the retina, the light-sensitive layer at the back of the eye. The supplied NHS source notes that treatment options can include injections, laser or surgery, depending on assessment. That sentence is the core of what a Chinese eye department would also be assessing: which retinal problem is present, how severe it is, and whether an intervention is likely to help.
What treatment can address is the specific retinal complication the ophthalmologist identifies. Injections, laser and surgery are used for different problems, and the choice follows the examination rather than the diagnosis label alone. What treatment cannot address is the underlying diabetes. No eye procedure replaces blood glucose control, blood pressure management or the diabetes care you already receive. It also cannot guarantee that vision will return to a previous level, because the retina may already have sustained changes that an intervention cannot reverse.
This distinction matters for an overseas patient because it changes what you are travelling for. You are not coming to China for a cure for diabetic retinopathy. You are coming, if the hospital accepts you, for a specialist assessment of a retinal problem and a decision about whether a procedure is appropriate. The assessment may conclude that no procedure is needed at this time, or that a different approach is better.
Why the retinal report and previous eye treatment matter most
The single most useful document for this decision is your most recent retinal report, including any imaging your eye clinic has already performed. A Chinese ophthalmologist reviewing your case needs to see what the retina looked like at the last assessment, not just a one-line diagnosis. If you have had previous injections, laser or eye surgery, the dates, the treated eye and the response recorded by your own clinic are directly relevant to whether a further procedure is suitable.
This is where incomplete records create a real problem. If the report is missing, the receiving clinician cannot see the trend, and the assessment may be limited to what can be observed on the day. That is not a reason to delay urgent local care, but it is a reason to request the specific documents before an overseas appointment. Ask your eye clinic for the retinal imaging report, the injection or laser history, and any letter that describes the current stage of retinopathy in each eye.
A practical administrative example: if your last retinal scan was performed at a different hospital from the one that gave you injections, the two records may sit in separate systems. Requesting both, with the dates, gives the Chinese reviewer a clearer picture than either document alone. You do not need to send a complete medical archive at first contact; a short summary and the key eye reports are enough to start.
How the treating team decides between injections, laser and surgery
Injections, laser and surgery are the treatment options that can be considered, depending on assessment. Which one is appropriate for a particular patient is not fixed by the diagnosis alone. The decision belongs to the treating ophthalmologist after examining your retina, reviewing your records and considering your overall health and diabetes control.
For an overseas patient, the useful question is not "which treatment will I get" but "what information does the treating team need to make that decision, and what will they tell me about the alternatives and restrictions". Ask how the proposed treatment would be coordinated with your existing diabetes and eye care. Ask what the follow-up schedule would look like and whether it can be delivered partly in your home country. Ask what would make the team decide against a procedure for you specifically.
These are questions to put to the hospital, not assumptions to carry into travel planning. A remote records review can give an opinion, but it does not establish final suitability or hospital acceptance. The hospital decides suitability after its own assessment.
Individual differences that change the answer
Two patients with the same retinopathy stage can receive different recommendations. The reasons include how long the changes have been present, whether one or both eyes are affected, what previous treatments were given and how the retina responded, and whether other eye conditions are present. Diabetes control and blood pressure also influence how the treating team weighs the risks and benefits of a procedure.
Because of this, no article can tell you whether you personally need treatment. Not every patient needs a procedure. That is not a hedge; it is the clinical reality. A patient with early changes may be monitored rather than treated. A patient with a specific complication may be offered an intervention. The only way to know which applies to you is an examination by an ophthalmologist who can see your retina.
This also means that a decision made in your home country may differ from one made in China, not because the medicine differs but because the assessment, the available records and the timing differ. If your local ophthalmologist has already recommended a procedure, bring that recommendation and the reasoning behind it. If your local team has advised monitoring, bring that too. The Chinese reviewer needs to understand what has already been considered.
Coordinating repeat eye reviews with your diabetes care
Diabetic retinopathy care is not a single event. It involves repeat eye reviews over time, and those reviews need to connect with your diabetes management. For an overseas patient, the practical question is how the proposed treatment and the repeat reviews would be coordinated with your existing diabetes and eye care. Ask the hospital how it would share findings with your home clinic, what interval it would recommend for the next review, and whether that review can be done locally.
Do not change any diabetes medicine on the basis of an eye appointment or an article. Diabetes treatment decisions belong to the clinician managing your diabetes. The eye team may comment on control as it relates to eye risk, but it should not be treated as a instruction to alter your medication. If a Chinese clinician suggests a change, that suggestion should be discussed with your diabetes team before anything is altered.
It is also worth asking, before travel, what the plan would be if the assessment finds that no procedure is needed. Would the trip still be worthwhile for a specialist opinion and a documented plan? Would the hospital provide a written summary you can take back to your own ophthalmologist? These questions help you judge whether the journey matches what you actually need.
Preparing records and questions before you enquire
Start with a short summary of your situation and your main question, not a complete medical archive. The most useful items at first contact are the retinal report from your most recent eye assessment, a list of previous eye treatments with dates, and a clear statement of what you want to know. If you have a recommendation from your local ophthalmologist, include it.
Then prepare the questions that only the treating team can answer. What does the assessment show in each eye? Is a procedure being considered, and what are the alternatives? What are the risks and restrictions for someone with your history? How would follow-up be arranged, and what would the hospital need from your diabetes team? What would make the team decide against treatment? These questions turn a general enquiry into a decision-relevant one.
The hospital decides suitability, and an initial enquiry does not commit you to any procedure or to buying a proxy consultation. You can begin with a free initial case review, which checks the available diagnosis, records and your main question, identifies missing information and suggests the relevant next step. That is not a diagnosis or a promise of acceptance. If you want to understand the procedure route in more detail, the relevant reference is linked below.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
